Wegovy Weight Loss Data UK: Clinical Results | Cured

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy Weight Loss Data - UK Price £69

Get the cheapest UK price on Wegovy from £69 plus £20 off your first order with code WEIGHTLOSSNEW.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off first order using code WEIGHTLOSSNEW

Treatment from £69

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check if you're eligible

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£99 £79.00

£19.75 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £99
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy Oral Pill
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy Oral Pill
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy Oral Pill
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy Oral Pill
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Clinical Weight Loss Data Across Every Wegovy Dose

Published on: June 03, 2026

Understanding wegovy weight loss data UK helps you set realistic expectations before starting treatment. At Cured Pharmacy, we've supported thousands of patients through their weight loss journey with Wegovy (semaglutide), and the clinical trial data consistently shows significant, sustained weight reduction when combined with lifestyle modifications.

STEP Trial Results: The Gold Standard for Wegovy Weight Loss Data UK

The STEP (Semaglutide Treatment Effect in People with obesity) clinical trial programme provides the most comprehensive wegovy weight loss data UK prescribers rely on when discussing expected outcomes [1]. STEP 1, the largest trial involving 1,961 adults with obesity, demonstrated an average body weight reduction of 14.9% over 68 weeks in patients receiving the full 2.4mg maintenance dose [1].

What makes this data particularly relevant for UK patients is the trial's inclusion criteria mirrored NICE guidelines: participants had a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [1]. This means the published results directly apply to the patient population eligible for Wegovy prescription in the UK.

Importantly, two-thirds of trial participants achieved at least 10% body weight reduction, and nearly half lost 15% or more of their starting weight [1]. These figures represent averages across diverse populations, and individual results varied based on adherence to the medication schedule and concurrent lifestyle modifications.

Weight Loss Outcomes by Wegovy Dose: From 0.25mg to 2.4mg

Wegovy follows a structured dose escalation schedule, and understanding weight loss at each stage helps patients track their progress against clinical benchmarks. The treatment begins at 0.25mg weekly for month one, serving primarily as a tolerability dose rather than a therapeutic one [2].

During the escalation phase (0.25mg to 1.7mg over 16 weeks), patients in the STEP trials typically experienced modest weight reduction of 2-5% of body weight [2]. This initial phase allows the body to adapt to semaglutide's effects on gastric emptying and appetite regulation whilst minimising gastrointestinal side effects.

The most significant weight loss occurs after reaching the 2.4mg maintenance dose, with the average patient continuing to lose weight for approximately 60 weeks before plateauing [1]. At Cured Pharmacy, our clinical team emphasises that the dose escalation schedule exists for safety reasons and should never be accelerated, even if initial weight loss feels slower than expected.

Maintenance Dose Outcomes: What the 2.4mg Data Shows

Once patients reach the 2.4mg maintenance dose, clinical trial data shows continued weight reduction for approximately one year before stabilisation [1]. The STEP 1 trial recorded peak weight loss at week 60, with patients maintaining an average 14.9% reduction through week 68 [1]. Patients who discontinued Wegovy during the STEP 4 withdrawal trial regained approximately two-thirds of their lost weight within one year, demonstrating that semaglutide requires ongoing use to maintain its effects [3].

Factors That Influence Individual Wegovy Weight Loss Results

Whilst clinical trial averages provide useful benchmarks, individual outcomes vary considerably based on several factors. Baseline BMI significantly impacts percentage weight loss: patients with higher starting BMIs often see larger absolute weight reductions but similar percentage decreases compared to those with lower BMIs [1].

Adherence to the medication schedule proved critical in the STEP trials. Patients who missed doses or discontinued treatment early showed markedly reduced outcomes compared to those who maintained consistent weekly injections [2]. At Cured Pharmacy, we provide dosing reminders and support to help patients maintain their injection schedule.

Concurrent lifestyle modifications amplify semaglutide's effects. STEP trial participants received counselling on reduced-calorie diets (500 kcal daily deficit) and 150 minutes of weekly physical activity [1]. Patients who engaged more actively with these lifestyle changes consistently achieved better outcomes than those relying on medication alone.

Age, Sex, and Metabolic Factors

Subgroup analyses from the STEP trials revealed that age and sex produced minimal differences in weight loss outcomes, though women slightly outnumbered men in achieving 15% or greater weight reduction [1]. Patients with pre-existing type 2 diabetes showed modestly lower weight loss compared to those without diabetes, averaging 9.6% versus 14.9% body weight reduction respectively [4]. This difference likely reflects the metabolic complications associated with long-standing insulin resistance rather than reduced medication efficacy.

Treatment Active Ingredient Average Weight Loss (Clinical Trials) Trial Duration Starting Price at Cured Pharmacy
Wegovy Semaglutide 2.4mg 14.9% body weight 68 weeks (STEP 1) From £69.00
Saxenda Liraglutide 3.0mg 6.4% body weight 68 weeks Not currently stocked
Mounjaro Tirzepatide 15mg 20.9% body weight 72 weeks (SURMOUNT-1) Not currently stocked
Orlistat Orlistat 120mg 3-5% body weight 52 weeks Not currently stocked

Comparing Wegovy Weight Loss Data to Other UK-Licensed Treatments

When UK prescribers discuss weight loss medication options, they often compare Wegovy's clinical data against other licensed treatments to determine the most appropriate choice. Semaglutide 2.4mg (Wegovy) demonstrated superior weight loss compared to liraglutide 3.0mg (Saxenda) in head-to-head comparisons, with average reductions of 15.8% versus 6.4% over 68 weeks [5].

Orlistat, the only weight loss medication available over-the-counter in UK pharmacies, produces average weight loss of 3-5% when combined with dietary modifications [6]. This makes Wegovy approximately three times more effective based on clinical trial data, though orlistat remains appropriate for patients who prefer non-injectable options or have contraindications to GLP-1 receptor agonists.

The newest entrant to the UK weight loss market, tirzepatide (Mounjaro), showed even greater efficacy in the SURMOUNT trials, with average weight reductions of 20.9% at the highest dose [7]. However, Wegovy remains the most widely prescribed injectable weight loss medication in the UK due to its established safety profile and earlier market availability. At Cured Pharmacy, our prescribers discuss all licensed options during your consultation to identify the most suitable treatment for your individual circumstances.

Long-Term Weight Maintenance Data: What Happens After One Year

One of the most clinically significant findings from the STEP trial programme concerns long-term weight maintenance. The STEP 5 trial extended observation to 104 weeks (two years), demonstrating that patients who continued Wegovy maintained an average 15.2% weight reduction from baseline [8].

This data directly addresses a common concern amongst UK patients: whether weight loss medications produce only temporary results. The trial evidence shows that sustained use of semaglutide maintains weight reduction, whilst discontinuation leads to weight regain [3]. This positions Wegovy as a long-term treatment rather than a short-term intervention.

At Cured Pharmacy, we emphasise that successful long-term outcomes require ongoing medication use combined with permanent lifestyle modifications. The clinical data shows that patients who view Wegovy as a tool to establish healthier eating patterns and activity levels achieve better sustained results than those who rely solely on the medication's appetite-suppressing effects.

Weight Regain After Discontinuation

The STEP 4 withdrawal trial provided crucial data on what occurs when patients stop Wegovy after achieving weight loss [3]. Participants who switched from active semaglutide to placebo after 20 weeks regained an average 6.9% of their body weight over the following 48 weeks, whilst those who continued treatment lost an additional 7.9% [3]. This 14.8 percentage point difference demonstrates semaglutide's ongoing role in weight maintenance rather than just initial reduction. UK prescribers use this data when discussing treatment duration expectations during consultations.

Starting Wegovy at Cured Pharmacy: Clinical Assessment and Pricing

All Wegovy prescriptions at Cured Pharmacy require completion of a clinical assessment by a UK-registered prescriber, in accordance with MHRA regulations and our GPhC registration (9012511). Our online consultation takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications to semaglutide therapy.

Wegovy is available from £79.00 at Cured Pharmacy, with transparent upfront pricing displayed before you begin your consultation. This represents the lowest guaranteed price for genuine UK-licensed Wegovy in the country. Your prescribed dose will be determined by our clinical team based on your current stage of treatment, and all medications are dispensed with complete dosing instructions.

We provide 100% discreet packaging and offer guidance on injection technique, managing potential side effects, and optimising your lifestyle modifications alongside medication. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees all clinical services to ensure you receive the highest standard of pharmaceutical care throughout your weight loss journey.

What to Expect During Your Wegovy Assessment

Your clinical assessment will evaluate your BMI, weight-related health conditions, previous weight loss attempts, and suitability for GLP-1 receptor agonist therapy. Our prescribers follow NICE guidelines when determining eligibility, typically requiring a BMI of 30 kg/m² or greater, or 27 kg/m² with associated comorbidities such as hypertension or type 2 diabetes. You'll receive a clear treatment plan outlining your dose escalation schedule and expected follow-up points. If Wegovy is not deemed appropriate for your circumstances, our clinical team will discuss alternative options or refer you back to your NHS GP for further evaluation.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
  2. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
  3. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M. A., Rudofsky, G., Tadayon, S., Wadden, T. A., Dicker, D., & STEP 4 Investigators. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
  4. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., Rosenstock, J., Shimomura, I., Viljoen, A., Wadden, T. A., Lingvay, I., & STEP 2 Study Group. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
  5. Rubino, D. M., Greenway, F. L., Khalid, U., O'Neil, P. M., Rosenstock, J., Sørrig, R., Wadden, T. A., Wizert, A., Garvey, W. T., & STEP 8 Investigators. (2022). Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA, 327(2), 138–150. https://doi.org/10.1001/jama.2021.23619 [accessed 13 August 2026]
  6. National Institute for Health and Care Excellence. (2014). Obesity: identification, assessment and management (Clinical guideline CG189). NICE. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
  7. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–218. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
  8. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., Jódar, E., Kandler, K., Rigas, G., Wadden, T. A., Wharton, S., & STEP 5 Study Group. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083–2091. https://doi.org/10.1038/s41591-022-02026-4 [accessed 13 August 2026]
  9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
  10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
  11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment and lifestyle modifications.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What is the average weight loss on Wegovy in the UK?
Clinical trial data shows UK-eligible patients lost an average of 14.9% of their body weight over 68 weeks on the full 2.4mg Wegovy dose, with two-thirds achieving at least 10% reduction. Individual results vary based on adherence and lifestyle modifications.
How much weight will I lose on each Wegovy dose?
The escalation doses (0.25mg to 1.7mg) typically produce 2-5% weight reduction over 16 weeks, whilst the 2.4mg maintenance dose drives the majority of weight loss, with peak reduction occurring around week 60.
Does Wegovy work better than other weight loss injections?
Head-to-head trials showed Wegovy (semaglutide 2.4mg) produced 15.8% average weight loss versus 6.4% with Saxenda (liraglutide 3.0mg) over 68 weeks. Newer tirzepatide showed higher efficacy at 20.9% in separate trials.
Will I regain weight if I stop taking Wegovy?
The STEP 4 withdrawal trial showed patients who discontinued Wegovy regained an average 6.9% body weight over 48 weeks, whilst those continuing treatment lost an additional 7.9%. Long-term use is typically required to maintain results.
How long does it take to see weight loss results on Wegovy?
Most patients notice initial weight reduction within 4-8 weeks of starting treatment, with progressive loss throughout the dose escalation phase. Peak weight loss typically occurs around week 60 on the 2.4mg maintenance dose.
Can I get Wegovy from Cured Pharmacy if my GP said no?
Our UK-registered prescribers conduct independent clinical assessments following MHRA and NICE guidelines. If you meet eligibility criteria (BMI ≥30 or ≥27 with comorbidities) and have no contraindications, you may be prescribed Wegovy even if previously declined elsewhere, subject to clinical approval.
What is the success rate of Wegovy for weight loss?
In the STEP 1 trial, 86.4% of patients on Wegovy achieved at least 5% weight loss, 69.1% achieved at least 10%, and 50.5% achieved 15% or greater reduction over 68 weeks. Success rates improve with adherence to medication and lifestyle modifications.
Is the wegovy weight loss data UK-specific or from international trials?
The STEP trials were international, multicentre studies including UK sites, with eligibility criteria matching NICE guidelines for UK prescribing. The data directly applies to UK patients meeting BMI thresholds of 30 kg/m² or 27 kg/m² with weight-related comorbidities.
What does the Wegovy weight loss data show for UK patients?
Clinical trials show Wegovy users lost an average of 15% body weight over 68 weeks. Cured Pharmacy provides access to clinically proven Wegovy with full prescriber support to help you achieve similar results safely.
How does Wegovy weight loss data compare to other weight loss injections?
Wegovy weight loss data demonstrates higher average weight loss than older GLP-1 treatments, with many patients losing 10-20% of their starting weight. Cured Pharmacy can help you compare options and choose the most effective treatment for your goals.
Is Wegovy available cheaper online than through my GP in the UK?
Yes, Wegovy is often more affordable through UK online pharmacies like Cured Pharmacy at £69, especially as NHS availability remains limited. You'll receive the same genuine medication with prescriber oversight at a lower cost.
Does the Wegovy price increase as I move up doses?
Yes, Wegovy prices vary by dose strength, starting at £69 for 0.25mg and increasing to £179 for the maintenance 2.4mg dose. Cured Pharmacy provides transparent pricing for every dose tier with £20 off your first order using code WEIGHTLOSSNEW.
Can I see real Wegovy weight loss data before starting treatment?
The STEP clinical trials published comprehensive Wegovy weight loss data showing sustained results over 68 weeks. Cured Pharmacy provides all clinical trial information during your consultation so you can make an informed decision about starting treatment.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 13 August 2026

Last updated on 13 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 13 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (13 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.